Potential impact of evidence-based medicine in acute coronary syndromes: Insights from GUSTO-IIb

Journal of the American College of Cardiology

Volumn 32, Issue 7, 1998, Pages 2023-2030

  Alexander, Karen P ^a   Peterson, Eric D ^a   Granger, Christopher B ^a   Casas, A Cecilia ^a   Van De Werf, Frans ^b   Armstrong, Paul W ^c   Guerci, Alan ^d   Topol, Eric J ^e   Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ST FRANCIS HOSPITAL   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CALCULATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; HEALTH CARE POLICY; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PATIENT COMPLIANCE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS;

EID: 0032422011     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00466-5     Document Type: Article

References (33)

1. Braunwald E., Mark D., Jones R., et al. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline Number 10, Publication 94-0602. 1994;Agency for Health Care Policy and Research, Rockville, MD.
2. Wilcox I., Freedman S.B., McCredie R.J., Carter G.S., Kelly D.T., Harris P.J. Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris. Am J Cardiol. 64:1989;845-848.
3. White L.D., Lee T.H., Cook E.F., et al. Comparison of the natural history of new onset and exacerbated chronic ischemic heart disease. J Am Coll Cardiol. 16:1990;304-310.
4. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 335:1996;775-782.
5. Ellerbach E.F., Jencks S.F., Radford M.J., et al. Quality of care for Medicare patients with acute myocardial infarction. JAMA. 273:1995;1509-1514.
6. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 28:1996;1328-1428.
7. Muller J.E., Turi Z.G., Pearle D.I., et al. Nifedipine and conventional therapy for unstable angina pectoris a randomized, double-blind comparison . Circulation. 69:1984;728-739.
8. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 319:1988;385-392.
9. Poole-Wilson P.A. Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarction. Am J Cardiol. 75:1995;4E-9E.
10. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine dose-related increase in mortality in patients with coronary heart disease . Circulation. 92:1995;1326-1331.
11. Held P., Yusuf S., Furberg C.D. Calcium channel blockers in acute myocardial infarction and unstable angina an overview . Br Med J. 299:1989;1187-1192.
12. Goldstein R.E., Boccuzzi S.J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation. 83:1991;52-60.
13. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 335:1996;1107-1114.
14. Garg R., Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456.
15. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the Survival and Ventricular Enlargement trial . N Engl J Med. 327:1992;669-677.
16. Cairns J.A., Gent M., Singer J., et al. Aspirin, sulfinpyrazone, or both in unstable angina results of a Canadian multicenter trial . N Engl J Med. 313:1985;1369-1375.
17. Lewis H.D., Davis J.W., Archibald D.G., et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 309:1983;396-403.
18. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction an overview of results from randomized controlled trials . JAMA. 270:1993;1589-1595.
19. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction an overview of the randomized trials . Prog Cardiovasc Dis. 27:1985;335-371.
20. Yusuf S., Wittes J., Friedman L. Overview of results of randomized clinical trials in heart disease. I: Treatments following myocardial infarction. JAMA. 260:1988;2088-2093.
21. Gurwitz J.H., Goldberg R.J., Chen Z., Gore J.M. B-Blocker therapy in acute myocardial infarction evidence for underutilization in the elderly . Am J Med. 93:1992;605-610.
22. Brand D.A., Newcomer L.N., Freiburger A., Tian H. Cardiologists' practices compared with practice guidelines use of beta-blockade after acute myocardial infarction . J Am Coll Cardiol. 26:1995;1432-1436.
23. Effect of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study . N Engl J Med. 316:1987;1429-1435.
24. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
25. Heidenreich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure a meta-analysis of randomized clinical trials . J Am Coll Cardiol. 30:1997;27-34.
26. Early catheterization is standard strategy in unstable angina/NQWMI results from GUSTO-IIb . (abstr) J Am Coll Cardiol. 29:1997;450A.
27. Management of unstable angina and non-Q wave acute myocardial infarction in the United States and Canada (the TIMI-III Registry). Am J Cardiol. 79:1997;1441-1446.
28. McLaughlin T.J., Soumerai S.B., Willison D.J., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction evidence for undertreatment in women and the elderly . Arch Intern Med. 156:1996;799-805.
29. Philbin E.F., Andreou C., Rocco T.A., Lynch L.J., Baker S.L. Patterns of angiotensin converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 77:1996;832-838.
30. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 90:1994;2103-2114.
31. Krumholz H.M., Vaccarino V., Ellerbeck E.F., et al. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons >65 years of age. Am J Cardiol. 79:1997;581-586.
32. Koenig W., Lowel H., Lewis M., Horman A. Long-term survival after myocardial infarction relationship with thrombolysis and discharge medication . Eur Heart. 17:1996;1199-1206.
33. Soumerai S.B., McLaughlin T.J., Spiegelman D., Hertzmark E., Thibault G., Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 277:1997;115-121.